Rhaeos
PrivateLast Round
Grant
Oct 9, 2023
Total Funding Raised
$19.74M
Momentum Score
25 /100
Company Overview
Rhaeos is a medical device company developing FlowSense, a noninvasive wearable sensor to monitor bodily fluid flow, initially for hydrocephalus patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rhaeos Comps
Public and private peers based on sector, stage, and business model.
Rhaeos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 9, 2023 | ||||
| Series A | Feb 16, 2023 | ||||
| Seed | Dec 23, 2021 | ||||
| Grant | Sep 16, 2021 | ||||
| Grant | Mar 1, 2021 | ||||
Grant | Oct 6, 2020 |
Key People
Founding team and executive leadership
Rhaeos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Grant |
| NIH RADx | Grant |
| Creative Ventures | Series A, Seed |
| University of Michigan Social Venture Fund | Seed |
| Lateral Capital | Series A, Seed |
| National Institute of Neurological Disorders and Stroke | Grant |
| Band of Angels | Seed |
Rhaeos Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rhaeos's valuation, stock price, and market status.
